Menu
For projects requiring a selection of antibodies designed to target the same antigen but with different epitopes. Purified Polyclonal antibodies are the final product.
Polyclonal package 2 creates a selection of antibodies to your chosen antigen which is checked via SDS-PAGE. Immunization using your chosen antigen is performed with the assurance of targeting the antigen via ELISA identification of collected antibodies.
$1,095.00
For projects requiring a selection of antibodies designed to target the same antigen but with different epitopes. Purified Polyclonal antibodies are the final product.
Polyclonal package 2 creates a selection of antibodies to your chosen antigen which is checked via SDS-PAGE. Immunization using your chosen antigen is performed with the assurance of targeting the antigen via ELISA identification of collected antibodies.
The end deliverables include your customized project report and results, 1-2ml of sera extracted prior to antigen immunization, 2-5mg of purified polyclonal antibodies, and the ELISA analysis of your resulting antibodies.
For our Polyclonal antibody package with antibodies contained in antisera as an end product, see here. For Polyclonal packages with Western blot and Immunohistochemistry assurance see here, and here .
Package Options | Service Items | Delivery |
|---|---|---|
Polyclonal Package 2 (From protein to antigen purified antibodies) |
| 1-2ml pre-immune sera 2-5mg purified antibodies ELISA result Project report |
| Brand | GL Biochem |
|---|
You must be logged in to post a comment.
There are no questions yet. Be the first to ask a question about this product.
DISCLAIMER: ConductScience and affiliate products are NOT designed for human consumption, testing, or clinical utilization. They are designed for pre-clinical utilization only. Customers purchasing apparatus for the purposes of scientific research or veterinary care affirm adherence to applicable regulatory bodies for the country in which their research or care is conducted.
Reviews
There are no reviews yet.